William Anderson, MD

Associate Professor, Pediatrics-Allergy/Immunology

FacultyPhoto
Medical School
  • MD, Georgetown University School of Medicine (2008)
Undergraduate School
  • BS, Bucknell University (PA) (2004)
Internship
  • University of Pittsburgh Medical Center/Children's Hospital of Pittsburgh (2009)
Residency
  • University of Pittsburgh Medical Center/Children's Hospital of Pittsburgh, Chief Resident, Internal Medicine - Pediatrics (2012)
Fellowships
  • National Jewish Medical and Research Center, Allergy and Immunology (2014)
Languages
English
Department
Pediatrics-Allergy/Immunology

Professional Titles

  • Co-Director, Multidisciplinary Asthma Clinic
  • Co-Director, Improving Pediatric to Adult Care Transition (ImPACT) Program
  • Clinical Medical Director, Allergy and Immunology Clinic
  • Director, Asthma Self-Care, Education, and Transition (ASCEnT) Program

Recognitions

  • Special Recognition for Fellows Research Mentorship, CHCO Allergy and Immunology Fellowship (2022)
  • Special Recognition for Fellow Education, CHCO Allergy and Immunology Fellowship (2022)
  • Special Recognition for Fellow Research Mentorship, CHCO Allergy and Immunology Fellowship (2021)
  • Patient-Family Experience 4-Star Award, Children's Hospital Colorado (CHCO) (2019)

Research Interests

My research focuses on the treatment of difficult-to-control and severe asthma, including incorporation of technology to help patients who are still having problematic asthma despite using their current medications. I am also interested in helping to improve the transition of pediatric patients to adult care.

Publications

  • McCulloch MR, Bothwell S, Brinton JT, Anderson WC 3rd. Effect of electronic medication monitoring on asthma outcomes in a multidisciplinary pediatric severe asthma clinic. Ann Allergy Asthma Immunol. 2024 Oct 1. [Epub ahead of print] PubMed PMID: 39362361
  • Anderson WC 3rd, Baptist AP, Eakin MN, Federman A, Murphy VE. Adherence Challenges and Strategies in Specific Groups With Asthma: Adolescents, Pregnancy, and Older Adults. J Allergy Clin Immunol Pract. 2024 Dec;12(12):3216-3222. PubMed PMID: 39122111
  • McCulloch M, Anderson WC 3rd. 'Tis the season for dupilumab?. Ann Allergy Asthma Immunol. 2024 Apr;132(4):413-414. PubMed PMID: 38569752
  • Ngo SY, Bothwell S, Brinton JT, Anderson WC 3rd. Preparing adolescents for independent asthma management: Gaps and opportunities. Ann Allergy Asthma Immunol. 2024 Jun;132(6):765-766. PubMed PMID: 38373580
  • De Keyser H, Vuong V, Kaye L, Anderson WC 3rd, Szefler S, Stempel DA. Reply to "Breath-taking compliance: Does lower adherence translate to inferiority?". J Allergy Clin Immunol Pract. 2023 Dec;11(12):3813-3814. PubMed PMID: 38065642
  • Ngo SY, Venter C, Anderson WC 3rd, Picket K, Zhang H, Arshad SH, Kurukulaaratchy RJ. Clinical features and later prognosis of replicable early-life wheeze clusters from two birth cohorts 12?years apart. Pediatr Allergy Immunol. 2023 Jul;34(7):e13999. PubMed PMID: 37492911
  • De Keyser H, Vuong V, Kaye L, Anderson WC 3rd, Szefler S, Stempel DA. Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease?. J Allergy Clin Immunol Pract. 2023 Jul;11(7):2087-2093.e3. PubMed PMID: 37088377
  • Anderson WC 3rd, Banzon TM, Chawes B, Papadopoulos NG, Phipatanakul W, Szefler SJ. Factors to Consider in Prescribing Asthma Biologic Therapies to Children. J Allergy Clin Immunol Pract. 2023 Mar;11(3):693-701. PubMed PMID: 36646381
  • Bush A, Fitzpatrick AM, Saglani S, Anderson WC 3rd, Szefler SJ. Difficult-to-Treat Asthma Management in School-Age Children. J Allergy Clin Immunol Pract. 2022 Feb;10(2):359-375. PubMed PMID: 34838706
  • Maslin K, Pickett K, Ngo S, Anderson W, Dean T, Venter C. Dietary diversity during infancy and the association with childhood food allergen sensitization. Pediatr Allergy Immunol. 2022 Jan;33(1):e13650. PubMed PMID: 34379815
  • DeKeyser H, Vuong V, Kaye L, Anderson WC III, et al. Differences in medication adherence by dosing schedule among patients with asthma and COPD. Presented as an oral abstract at the American Academy of Allergy Asthma and Immunology Annual Scientific Meeting. Phoenix, AZ. February 2022
  • McCulloch M, Bothwell S, Brinton J, Anderson WC III. Impact of electronic medication monitoring on pediatric asthma severity and control: real-world experience from a multidisciplinary clinic. Presented as an oral abstract at the American Academy of Allergy Asthma and Immunology Annual Scientific Meeting. Phoenix, AZ. February 2022.
  • Anderson III WC, Disabato J. TPT "2.0": modifications to the Transition Planning Tool to improve care team requested functionalities.
  • Urbine V, Vann EF, Anderson III WC. Expanding access to pediatric to adult transition planning services via a supplementary telehealth program.
  • Hepp B, Ramos J, Scott J, Heinrichs S, Disabato J, Anderson III WC. A multidisciplinary pilot program to improve implementation of transition best practices.
  • Stukus D (Host). 07/14/2022. Navigating the Expanding Spectrum of Biologics. Episode 74. Conversations from the World of Allergy. Audio Podcast. American Academy of Allergy Asthma and Immunology. http://aaaai1public.blob.core.windows.net/media/conversations/episode-74.mp3
  • Zacharias E (Host). 09/28/2022. COPIC Medical Foundation Grant Recipient: Children’s Hospital Colorado Foundation. Episode 46. Within Normal Limits. Audio Podcast. COPIC. https://www.callcopic.com/resource-center/within-normal-limits
  • Caring for Patients with Severe Asthma. Pediatric Health Care Professionals Resources. Children's Hospital Colorado. https://www.youtube.com/watch?v=3PEOhszb4dc
  • What is dupilumab and when should it be used? 4AI4U. American Academy of Allergy Asthma and Immunology. https://www.youtube.com/watch?v=EKvqdmQbTaU
  • Tezepelumab - the new biologic for asthma. 4AI4U. American Academy of Allergy Asthma and Immunology. https://www.youtube.com/watch?v=pSOFVqHrVYw
  • Anderson WC 3rd, Gondalia R, Hoch HE, Kaye L, Barrett M, Szefler SJ, Stempel DA. Assessing asthma control: comparison of electronic-recorded short-acting beta-agonist rescue use and self-reported use utilizing the asthma control test. J Asthma. 2021 Feb;58(2):271-275. PubMed PMID: 31668103
  • Anderson WC 3rd, Gondalia R, De Keyser HE, Kaye L, Szefler SJ, Stempel DA. Digital assessment of medication utilization by age and diagnosis of asthma or COPD. J Allergy Clin Immunol Pract. 2021 Apr;9(4):1723-1725. PubMed PMID: 33212238
  • Bush, A, Fitzpatric AM, Saglani S, Anderson III, WC, Szefler SJ. Difficult-to-treat asthma management in school-aged children. J Allergy Clin Immunol Pract. 2021 Nov 24:S2213-2198(21)01288-5
  • Gondalia R, Anderson WC III, Kaye L, De Kyser H, et al. Medication adherence was greater in a digital asthma platform consisting of control and rescue vs. controller inhalers alone.
  • Anderson WC III, Bothwell S, Camacho M, Brinton JT. Objective controller medication adherence patterns in pediatric patients with asthma in a high-risk multidisciplinary asthma clinic.
  • Barnes MJ, Camacho M, Anderson III WC. Identification of inducible laryngeal obstruction by speech language pathology in a severe pediatric asthma clinic.
  • Ngo S, Bothwell S, Brinton J, Anderson III WC. Pediatric to adult health care transition preparation practices and transfer in young adults with asthma.
  • Anderson III WC, Disabato J. Distinguishing reality versus perception in provider-identified barriers to transition from pediatric to adult care.
  • Vann EF, Urbine V, Camacho M, Anderson III WC. The Impact of provider-directed communication strategies on ?engagement with a pediatric to adult transition program.
  • Anderson WC III, Gondalia R, De Keyser H, et al. Digital assessment of medication utilization by ageanddiagnosisofasthmaorCOPD. JournalofAllergyandClinicalImmunology:InPractice 2021;9(4):1723-25.
  • De Keyser HEH, Kaye L, Anderson WC, Gondalia R, Theye B, Szefler SJ, Stempel DA. Electronic medication monitors help determine adherence subgroups in asthma. Respir Med. 2020 Apr;164:105914. PubMed PMID: 32094102
  • Cotter JM, Tyler A, Reese J, Ziniel S, Federico MJ, Anderson Iii WC, Kupfer O, Szefler SJ, Kerby G, Hoch HE. Steroid variability in pediatric inpatient asthmatics: survey on provider preferences of dexamethasone versus prednisone. J Asthma. 2020 Sep;57(9):942-948. PubMed PMID: 31113252
  • Anderson WC III, Gondalia R, Hoch HE, et al. Assessing asthma control: comparison of electronic- recorded short-acting beta-agonist rescue use and self-reported use utilizing the asthma control test. Journal of Asthma 2021;58(2):271-5.
  • Duffey H, Anderson WC 3rd. It's Time to Start Phenotyping Our Patients with Asthma. Immunol Allergy Clin North Am. 2019 Nov;39(4):561-572. PubMed PMID: 31563189
  • Anderson WC 3rd, Gondalia R, Hoch HE, Kaye L, Szefler SJ, Stempel DA. Screening for inhalation technique errors with electronic medication monitors. J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):2065-2067. PubMed PMID: 30776523
  • Anderson WC 3rd, Szefler SJ. Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic?. Ann Allergy Asthma Immunol. 2019 Apr;122(4):367-372. PubMed PMID: 30703438
  • Cotter JM, Tyler A, Reese J, Ziniel S, Federico MJ, Anderson Iii WC, Kupfer O, Szefler SJ, Kerby G, Hoch HE. Steroid variability in pediatric inpatient asthmatics: survey on provider preferences of dexamethasone versus prednisone. J Asthma. 2019 Jun 12;:1-7. [Epub ahead of print] PubMed PMID: 31113252
  • Anderson W, Hoch H, Gondalia R, et al. Digital assessment of asthma controller and rescue medication use as children transition into adulthood. Journal of Allergy and Clinical Immunology 2019;143(2, Suppl): AB91. Presented as a poster at the American Academy of Allergy, Asthma, and Immunology Annual Scientific Meeting. San Francisco, California. March 2019.
  • Gondalia R, Anderson W, Hoch H, et al. Assessing the sensitivity and specificity of self-reported short-acting beta agonist (SABA) inhaler use with electronic medication monitors (EMMs). Journal of Allergy and Clinical Immunology 2019;143(2, Suppl): AB169. Presented as a poster at the American Academy of Allergy, Asthma, and Immunology Annual Scientific Meeting. San Francisco, California. March 2019.
  • Anderson WC III, Hoch HE, Gondalia R, et al. Real-life patterns of short-acting beta-agonist use in patients with COPD vary by time of day and season. American Journal of Respiratory and Critical Care Medicine. 2019;199:A5933. Presented as a rapid abstract at the American Thoracic Society Scientific Meeting. Dallas, Texas. May 2019.
  • Hoch HE, Anderson WC III, Gondalia R, et al. Digitally recorded controller and rescue medication use vary by age in patients with asthma. American Journal of Respiratory and Critical Care Medicine. 2019;199:A5931. Presented as a rapid abstract at the American Thoracic Society Scientific Meeting. Dallas, Texas. May 2019.
  • Gondalia R, Anderson W, Hoch H, Szefler S, Stempel D. Prevalence of short-acting beta agonist (SABA) alone and in conjunction with inhaled corticosteroids (ICS). Annals of Allergy Asthma and Immunology. 2019:123;5,Supplement: S42. Presented at the American College of Allergy Asthma and Immunology Annual Meeting in Houston, TX. November 2019.
  • Anderson W, Gondalia R, Hoch H, Barrett M, Szefler S, Van Sickle D, Stemple D. Nighttime short-acting beta-agonist (SABA) in asthma and COPD. European Respiratory Journal 2019. 54;Suppl 63:PA859. Presented at the European Respiratory Society Meeting. September 2019.
  • Anderson WC III. Chapter 8: Managing adolescent asthma: more than just medications. 119- 136. Allergies and Adolescents: Transitioning Towards Independent Living. 2018. Springer Press: New York, NY.
  • Anderson WC III, Szefler SJ. Controlling the risk domain in pediatric asthma through personalized care. Seminars in Respiratory and Critical Care Medicine 2018;39:36-44.
  • Hoch HE, Anderson WC III, Szefler SJ. Chapter 48: Modern molecular therapies for application in managing childhood asthma. 747-755. Kendig and Chernick’s Disorders of the Respiratory Tract in Children, 9th Edition. 2018. Elsevier: Philadelphia, PA.
  • Anderson WC III, Stukus D. Pediatric asthma masqueraders. Journal of Allergy and Clinical Immunology: In Practice 2018;6:1083-85.
  • Anderson WC III, Brinton JT, Kaye L, et al. Real-life patterns of short-acting beta-agonist use in persistent asthmatics vary by age, time of day, and season. Journal Allergy and Clinical Immunology 2018;141(2, Supplement):193. Presented as a poster at the American Academy of Allergy, Asthma, and Immunology Annual Scientific Meeting. Orlando, Florida. March 2018.
  • Kaye L, Hoch HE, Szefler S, Anderson WC, et al. Real-life patterns of asthma controller use vary by age, time of day and season. Journal of Allergy and Clinical Immunology 2018;141(2, Supplement): AB61. Presented as a poster at the American Academy of Allergy, Asthma, and Immunology Annual Scientific Meeting. Orlando, Florida. March 2018.
  • Anderson WC, Hoch HE, Kaye L, et al. Association between objective short-acting beta-agonist use and self-reported asthma control test scores among adults with asthma. Presented as a poster during a Thematic Poster Session at the American Thoracic Society Scientific Meeting. San Francisco, California. May 2018.
  • Hoch HE, Anderson WC, Tuffli M, et al. Using digital technology to identify adherence phenotypes may identify appropriate time for intervention. Presented as a poster during a Thematic Poster Session at the American Thoracic Society Scientific Meeting. San Francisco, California. May 2018.
  • Hoch HE, Kaye L, Anderson WC, et al. Comparing objective inhaler use among COPD and asthma populations. Accepted. Presented as a poster at the European Respiratory Society Meeting. Paris, France. September 2018.
  • Anderson WC, Hoch HE, Gonalia R, et al. Asthma control evaluated with electronic medication monitor (EMM)-defined occasions of short-acting beta-agonist inhaler use. Annals of Allergy Asthma and Immunology 2018;121(Supplement 1): S7-8. Presented as an ePoster at the American College of Allergy, Asthma, and Immunology Annual Scientific Meeting. Seattle, WA. November 2018.
  • Anderson WC, Hoch HE, Gondalia R, et al. Frequency of improper inhaler technique identified by electronic medication monitor actuation timing. Annals of Allergy Asthma and Immunology 2018;121(Supplement 1): S40. Presented as an oral abstract at the American College of Allergy, Asthma, and Immunology Annual Scientific Meeting. Seattle, WA. November 2018.
  • Hoch HE, Kaye L, Anderson WC, et al. Benefit of smartphone alerts to improve adherence to inhaled asthma controllers. Annals of Allergy Asthma and Immunology 2018;121(Supplement 1): S40. Presented as an oral abstract at the American College of Allergy, Asthma, and Immunology Annual Scientific Meeting. Seattle, WA. November 2018.
  • Stukus DR, Anderson WC III. Chapter 7: Asthma: a heterogeneous and challenging chronic condition. 95-118. Allergies and Adolescents: Transitioning Towards Independent Living. 2018. Springer Press: New York, NY
  • Anderson WC III. Chapter 8: Managing adolescent asthma: more than just medications. 119-136. Allergies and Adolescents: Transitioning Towards Independent Living. 2018. Springer Press: New York, NY.
  • Anderson WC 3rd, Apter AJ, Dutmer CM, Searing DA, Szefler SJ. Advances in asthma in 2016: Designing individualized approaches to management. J Allergy Clin Immunol. 2017 Sep;140(3):671-680. PubMed PMID: 28709967
  • Anderson WC 3rd. Incorporating technology to advance asthma controller adherence. Curr Opin Allergy Clin Immunol. 2017 Apr;17(2):153-159. PubMed PMID: 28118240
  • Anderson WC III, Brinton JT, Meier MR Ford L, Lineberry S, Sakamoto C, Tomisato M, Zeiger RS, Lemanske RF, Martinez FD, Guilbert TW, Bacharier LB, Mauer DM, Szefler SJ. The effects of inhaled fluticasone propionate on seasonal exacerbations in preschool-aged children at high risk for asthma. Journal of Allergy and Clinical Immunology 2017;139(2, Supplement):AB382
  • Anderson WC III, Gleason MC, Miyazawa N, Szefler SJ. Approach current and new drug therapies for pediatric asthma. Pediatric Clinics of North America 2017;64(6):1197-1207.
  • Cotter J, Hoch H, Federico M, Kupfer O, Ziniel S, Anderson W, Reese J, Tyler A. Increasing Dexamethasone Use in Pediatric Inpatient Asthma Exacerbations: Have Outcomes Changed? Poster presented at: Pediatric Hospital Medicine (PHM) Annual Meeting (2017); Nashville, TN.
  • Cotter J, Hoch H, Federico M, Tyler A, Anderson W, Kupfer O, Ziniel S, Reese J. Practice Variability in Steroid Use in Pediatric Inpatient Asthma Exacerbations. Poster presented at: Pediatric Academic Society (PAS) Annual Meeting (2017); San Francisco, CA.
  • Anderson WC III. Change in routine could make asthma worse. KUSA 9News. August 23, 2017. Retrieved from http://www.9news.com/mobile/video/news/health/change-in-routine-could-make-asthma-worse/73-2698440 .
  • Anderson B. Asthma. Charting Pediatrics Podcast. Released August 22, 2017. Available at https://www.childrenscolorado.org/health-professionals/publications/charting-pediatrics/ .
  • Liu AH, Anderson WC 3rd, Dutmer CM, Searing DA, Szefler SJ. Advances in asthma 2015: Across the lifespan. J Allergy Clin Immunol. 2016 Aug;138(2):397-404. PubMed PMID: 27497278
  • Federico MJ, Hoch HE, Anderson WC 3rd, Spahn JD, Szefler SJ. Asthma Management for Children: Risk Identification and Prevention. Adv Pediatr. 2016 Aug;63(1):103-26. PubMed PMID: 27426897
  • Anderson WC 3rd, Szelfer SJ. Reply. J Allergy Clin Immunol. 2016 Jun;137(6):1916. PubMed PMID: 27045584
  • Anderson WC III. When your patient's asthma controller isn't in control: troubleshooting pediatric asthma in school-aged children. Practice Update. Children's Hospital Colorado. Spring 2016.
  • Anderson WC III. When your patient's asthma controller isn't in control: troubleshooting pediatric asthma in school-aged children. Colorado Family Physician. 2016; 3rd Quarter:28-31.
  • Anderson WC 3rd, Szefler SJ. New and future strategies to improve asthma control in children. J Allergy Clin Immunol. 2015 Oct;136(4):848-59. PubMed PMID: 26318072
  • Anderson WC, Stukus DR. Pediatric asthma masqueraders. Journal of Allergy and Clinical Immunology in Practice. In Press

Professional Memberships

  • American Academy of Allergy, Asthma, and Immunology (AAAAI), Fellow
  • Colorado Allergy and Asthma Society, Member
  • American College of Allergy, Asthma, and Immunology (ACAAI), Fellow
  • Western Society of Allergy, Asthma, and Immunology, Member

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Hospital Affiliation
  • Children's Hospital Colorado

Specialty Information

Specialties
  • Pediatrics, Board Certification (2012, 2022)
  • Internal Medicine, Board Certification (2012, 2022)
  • Allergy and Immunology, Board Certification (2014, 2024)
Conditions & Treatments
  • Immune System - Allergies
  • Immune System - Anaphylaxis
  • Immune System - Urticaria (Hives)
  • Lungs and Breathing - Asthma
  • Immune System - Angioedema
  • Immune System - Rhinitis
  • Immune System - Sinusitis
  • Food, Nutrition and Metabolism - Food Allergies
  • Food, Nutrition and Metabolism
  • Immune System
  • Immune System - Eczema
  • Lungs and Breathing
  • Lungs and Breathing - Respiratory Disease
  • Symptoms and Manifestations - Breathing Problems
  • Symptoms and Manifestations
  • Symptoms and Manifestations - Cough
  • Ear, Nose, and Throat (ENT) - Allergic Rhinitis
  • Ear, Nose, and Throat (ENT)
Clinical Interests
My primary clinical interest is asthma, including difficult-to-treat and severe asthma. I am the co-director of the Multidisciplinary Asthma Clinic, which takes a team approach to improve asthma care for children by working with Allergy, Pulmonary Medicine, Social Work, Speech Therapy, and Nutrition. I also see patients who have environmental allergies, food allergies, nasal symptoms, drug allergies, and hives. While I am happy to see children of all ages, I am particularly interested in helping adolescents transition their care from pediatric to adult medicine.

Care Philosophy
Before going into Allergy, I completed a combined residency treating both children and adults. Given this background, I care deeply about how a child's asthma and allergies can affect them both now and throughout their lives. I appreciate the significant impact these conditions make on both the child's and family's quality of life. I partner with families to provide comprehensive, efficient, personalized care for my patients that fits their needs. I value a multidisciplinary team-based approach to support patients and their families.

Personal Interests
I enjoy exercising, cuddling with my dog, cooking, and playing trivia.

Public Speaking
Yes
Diagnosis and management of severe and difficult-to-treat asthma and co-morbid conditions; electronic medication monitoring; biologics; transition from pediatric to adult care


School of Medicine

CU Anschutz
Fitzsimons Building

13001 East 17th Place

Aurora, CO 80045

303.724.5375

School
General
Students